Stable oral formulation containing benzimidazole derivative

Details Stable oral formulation containing benzimidazole derivative Stable oral formulation containing benzimidazole derivative

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 31/355 (2006.01) A61K 31/44 (2006.01)

Patent

CA 2426175

An enteric formulation containing at least one benzimidazole derivative, said formulation comprising: a core containing at least one benzimidazole derivative and at least one lipophilic antioxidant, and an enteric envelope protecting the core at least at a pH of 3 to 5, preferably at a pH pf 1 to 5.

L'invention concerne une formulation entérique renfermant au moins un dérivé de benzimidazole, composée de la manière suivante: un noyau qui contient au moins un dérivé de benzimidazole et au moins un antioxydant lipophile, et une enveloppe entérique de protection du noyau ayant un pH au moins compris entre 3 et 5, et de préférence compris entre 1 et 5.

Affiliated with

Also associated with

Rating

Stable oral formulation containing benzimidazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable oral formulation containing benzimidazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable oral formulation containing benzimidazole derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1467296